Magnetic nanoparticle (MNP) labeling of stem cell has been proved its efficacy for cell trafficking. Most of the labeling technique requires mixture of iron oxide nanoparticles and transfection agent. Stem cells with ionic MNP without the aid of transfection agent were labeled previously. The possibility of high efficiency labeling of cultured cancer cell, HeLa cell, by using ionic MNP is proposed. The labeled cell morphology was observed and the intracellular iron content was determined by spectrophotometry. The cell character change was evaluated by flow cytometry where front scattering count and side scattering count (SSC) were recorded. The imaging ability of the labeling method was determined by T2 weighted magnetic resonance (MR) imaging. Labeled MNPs were accumulated at cytoplasm is observed and the iron content of labeled cell could reach 27 pg/cell. There is no cell diameter change but the cell granularity increased according to SSC data from flow cytometry. Under clinical 1.5 T MR imaging, we could detect labeled cells easily were detected at the cell number of 1 × 10 5 . It is concluded that labeling of cancer cell with ionic MNPs without transfection agent is an efficient labeling method which will provide non-invasive imaging method for monitoring cancer behavior.
INTRODUCTION
Magnetic nanoparticles (MNPs) composed of iron oxide are widely used as magnetic resonance imaging contrast medium. 1 The cores of these nanoparticles are made up of either Fe 3 O 4 or r-Fe 2 O 3 . 1,2 To prevent particle aggregation or precipitation, the particles are coated with either dextran or carboxydextran. Ren-ai Rd., Taipei, Taiwan. Tel.: +886-2-33665269; Fax: +886-2-33665268; E-mail: jlwang@ntu.edu.tw 259 materials which could be degraded safely in the human body.
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Clinically, MNPs have been used as liver specific or blood pool MR contrast medium. 4, 6 In addition, it has been used for stem cell labeling. The labeled stem cells could be identified in vivo under MRI. 7 This technique helps us to understand the fate of stem cells in vivo without damaging the living organism. However, for optimizing the efficiency of stem cell labeling, transfection agent such as protamine sulfate is usually added. 8, 9 There is a debate on the influence of transfection agent on the labeled cells. 
MATERIAL AND METHODS

Cell Culture and Iron Oxide Treatment
HeLa cell was purchased from the Culture Collection and Research Center (CCRC, Hsin-Chu, Taiwan). The cells were cultured in Dulbecco's modified Eagle Medium (DMEM) (Cellgro, Herndon, VA, USA), supplemented with 10% heat-inactivated fetal bovine serum (FBS), penicillin (50 U/ml), and streptomycin (0.05 mg/ml). The cells were incubated at 37
CO 2 . For incubation with MNPs, Ferucarbotran, a clinically approved ionic MNPs was added to the culture medium at concentrations of 1, 10 or 100 µg Fe/ml respectively which corresponds to 0.11, 1.1, and 11 times plasma concentration after intravenous administration of Ferucarbotran at suggested dosage.
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Iron Content Measurement
Iron concentration of HeLa cell was determined as described in Refs. 13 and 14. Briefly, 1×10 5 SPIO labeled human HeLa were lyzed using 1% sodium dodecyl sulfate (SDS). The solution was then examined spectrophotometrically at 248.3 nm. The iron concentration was determined by comparing the absorption value of each sample with six Ferucarbotran containing standards with iron concentration ranging from 5000 to 2,000,000 µg Fe/ml.
Morphology and Particle Uptake Efficiency Assay
The cells were imaged using an inverted microscope (Nikon Eclipse TS100, Tokyo, Japan) at 200 × magnification. Prussian blue staining was used for localization of the intracellular iron oxide as described in Ref. 15 . Flow cytometry (FACS Calibur, Becton Dickinson, San Jose, CA, USA) was applied for the determination of granularity change and cell diameter between MNPs treated and non-treated groups. 16 Briefly, macrophages were collected by measuring side scattering counts (SSC) and front scattering counts (FSC). For each group of macrophages, 10,000 counts were measured and the results were graphed with the assistance of computer software (CellQuest, Becton Dickinson, San Jose, CA, USA).
MRI Image
The confirmation of MNPs loading was further investigated by MR imaging as described in Ref. 
RESULTS
Prussian blue stain of HeLa cells revealed abundant deep blue granules in the cytoplasm of cells treated with 100 µg Fe/ml MNPs and could also be found at lesser degree in cells exposed to MNPs at the concentration of 10 µg Fe/ml. The cell nucleus is not stained. The blue staining could not be found in cells exposed to MNPs at the concentration of 0.1 µg Fe/ml (Fig. 1) . For quantification of MNPs uptake into cells, HeLa cells exposed to 1, 10, and 100 µg Fe/ml of MNPs were further analyzed for their iron content. We observed that the time and dose dependent manner of iron content increase. The iron content inside the cell is richest in cells exposed to 100 µg Fe/ml of MNPs for 18 h. The iron content reached 27 pg/cell, which is 1.9 times higher compared to cells treated for only 1 h (Fig. 2) .
The cell behavior changes were determined by flow cytometry. The FSC versus SSC was measured and the distribution indicated the cell morphology and the cell debris. There is no significant increase in cell debris in each groups compared with control group where no ionic MNPs were added (Fig. 3) .
The pattern of histograms of FSC was measured as a means for evaluating cell morphology. There is no evidence of cell size change in all of the groups which was evidenced by similar count peak at the same level (Fig. 4) .
The pattern of SSC was shifted to left side when the cells were treated with higher concentration of ionic MNPs and longer exposure time (Fig. 5(A) ). The pattern could be demonstrated more clearly at merged plot where HeLa cells were exposed to MNPs for 18 h at different MNPs concentration (Fig. 5(B) ). The cells were further investigated for its labeling ability by directly scanned under 1.5 T clinical MRI. There is marked signal intensity drop in cells treated with 100 µg Fe/ml MNPs at 18 h. The signal intensity drop also revealed incubation dose and time-dependent manner. There is no signal intensity change at control group, whereas the signal intensity drop could be observed in cells treated from 10 to 100 µg Fe/ml when the incubation time reaches 18 h (Fig. 6 ).
DISCUSSION
Labeling of cells with MNPs for cell trafficking provide a non-invasive method for monitoring cell implantation.
However, transfection agent such as protamine sulfate is usually needed for facilitating cell labeling. We previously reported a new method for labeling human mesenchymal stem cells without transfecting agent. Using this technique we can observe labeled cell at single cell level. 11 We proved in this paper that the same labeling method could be applied into cancer cells. Besides, the labeling efficiency is comparable in HeLa cell which has 27 pg Fe/cell compared to human mesenchymal stem cells that has 23.4 pg Fe/cell in our previous study. This finding further support the application ability of this labeling method. We reported that the ingested MNPs will be transported to membrane bound intracellular organelle which was supposed to be lysosomes. 18 This phenomenon also supports the finding of SSC increase in cells with MNPs uptake. This measuring method would be a fast, robust technique to analyze MNPs labeling efficiency since the MNPs attached to the cell membrane will not be detected. We previously noted that the iron content of the macrophage cell was correlated with labeling efficiency proved by flow cytometry and MRI signal intensity change. 18 The same correlation could be found in cancer cells. Labeling cancer cells with MNPs have potential benefits in the study of cancer biology. First, it provides us a non-invasive method for monitoring cancer invasion. Second, at the assistance of high resolution MRI, single cancer cell could be detected and be monitored for cancer cell migration, chemotaxis, and metastasis. Third, it is known that cancer cells will interact with adjacent cells such as macrophages. 19 And we just developed T1 contrast nanorods. 20 By labeling these two kinds of cells with either T1 or T2 contrast particle, the interaction between these cells could be observed in living organism, which work could only partially be done by intravital microscopy. Although we proved the labeling efficiency of ionic MNPs in cancer cells, the uptake mechanism, and its potential effect toward cancer cells is not fully understand. The MNPs uptake pathway was proposed to be clathrin receptor related, consequently, future studies by different uptake inhibitor assay should be analyzed.
It was reported that the duration of MNPs labeled stem cells could last up to months. 21 However, cancer cells proliferate rapidly and the intracellular MNPs might be divided rapidly. 19 It would be clinical significant to know how long the MNPs could be detected in these cancer cells. It is proved that no cell differentiation change or viability change after ionic MNPs labeling in human mesenchymal stem cells.
11 However, the cell behavior change should be further investigated since the cancer cell has different cell behavior including rapid proliferation, migration, and invasion compared to stem cells.
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Understanding these effects might have benefits in the treatment of malignancy.
CONCLUSION
We have developed high efficiency labeling method and imaging ability of HeLa cell, one kind of cancer cell by using ionic MNPs without transfecting agent. The optimum labeling efficiency was incubation at the concentration of 100 µg Fe/ml for 18 hours. This method will provide us the opportunity for studying cancer biology in living animal by clinical MR imaging facility.
